Articles
Special Challenges In Production Of Biopharmaceutical Dosage Forms
November 25, 2009
Click Here To Download:
•Feature Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
•Feature Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
•Feature Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
By Michael J. Akers
Biopharmaceutical products are potent, reactive, unstable, and expensive. As a consequence, all aspects of their handling, identity control, processing, packaging, and storage require utmost attention, if not perfection.
When mistakes occur during one or more segments of biopharmaceutical dosage form production, companies lose precious time and spend valuable resources investigating and controlling the impact of those mistakes on good manufacturing practice (GMP) attributes including safety, identity, strength, purity, and quality.
Reprinted With Permission From BioProcess International
Click Here To Download:•Feature Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
